rxstat › Classes › Adrenergics, Inhalants
Adrenergics, Inhalants: shortage status in Canada
2 of the 7 adrenergics, inhalants rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Salbutamol (Ventolin Nebules P.f. -) Partial shortage 6 of 23 reported products affected
Salbutamol Ipratropium Bromide (Combivent Udv) Partial shortage 1 of 6 reported products affected
Formoterol (Foradil Dry) Discontinued 0 of 1 reported products affected
Indacaterol (Onbrez Breezhaler) Discontinued 0 of 1 reported products affected
Mometasone Furoate Formoterol (Zenhale) Discontinued 0 of 2 reported products affected
Salmeterol (Serevent Diskus) No current shortage
Salmeterol Fluticasone Propionate (Advair) No current shortage
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.